Want to buy for someone else? You can purchase a token at check out.
Overview
Nearly 26 million Americans have been diagnosed with asthma, a disease marked by variable and recurring symptoms, airflow obstruction, bronchial hyper-responsiveness, and underlying inflammation. Inflammation of the airways and airway hyper-responsiveness are the hallmark pathophysiological features of asthma, resulting in the typical symptoms: coughing, wheezing, chest tightness, and breathlessness. The goal of asthma pharmacotherapy is to relieve or minimize symptoms by targeting the underlying pathophysiological processes. Because of the high prevalence of asthma, all clinicians must be up to date on the current guidelines for the diagnosis and treatment of this chronic illness. This course will summarize the key guideline changes, with a focus on adults.
Goals and Learning Outcomes
- List at least three common symptoms of asthma.
- Describe the asthma severity and control classifications.
- Differentiate between long-term controller and quick-relief asthma medications and describe at least one potential adverse effect for each medication in each class.
Course Details
Course Originally Released on : 12/8/2008
CE496
Course Author
EdD, RRT, RCP
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.